Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Rare Diseases 1Obsessive-Compulsive Disorder 1Neurologic Manifestations 1Mental Disorders 1Anxiety Disorders 1

Interventions

Temozolomide 2Bevacizumab 2Valproic Acid 1Therapeutics 1Sorafenib 1Sildenafil Citrate 1Radiotherapy 1Irinotecan 1Clomipramine 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neurologic Manifestations × Clomipramine × Clear all
NCT00004310 2005-06-24

Phase II Randomized Study of Intravenous Versus Oral Clomipramine in Patients With Obsessive Compulsive Disorder

National Center for Research Resources (NCRR)

Phase 2 Unknown
76 enrolled

Anxiety Disorders, Mental Disorders, Neurologic Manifestations, Obsessive-Compulsive Disorder, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡